BACKGROUND: Among asthmatic subjects, bronchodilator response (BDR) to inhaled beta(2)-adrenergic agonists is variable, and the significance of a consistent response over time is unknown. OBJECTIVE: We assessed baseline clinical variables and determined the clinical outcomes associated with a consistently positive BDR over 4 years in children with mild-to-moderate persistent asthma. METHODS: In the 1041 participants in the Childhood Asthma Management Program, subjects with a change in FEV(1) of 12% or greater (and 200 mL) after inhaled beta(2)-agonist administration at each of their yearly follow-up visits (consistent BDR) were compared with those who did not have a consistent BDR. RESULTS: We identified 52 children with consistent BDRs over the 4-year trial. Multivariable logistic regression modeling demonstrated that lower baseline prebronchodilator FEV(1) values (odds ratio, 0.71; P < .0001), higher log10 IgE levels (odds ratio, 1.97; P = .002), and lack of treatment with inhaled corticosteroids (odds ratio, 0.31; P = .009) were associated with a consistent BDR. Individuals who had a consistent BDR had more hospital visits (P = .007), required more prednisone bursts (P = .0007), had increased nocturnal awakenings caused by asthma (P < .0001), and missed more days of school (P = .03) than nonresponders during the 4-year follow-up. CONCLUSIONS: We have identified predictors of consistent BDR and determined that this phenotype is associated with poor clinical outcomes.
RCT Entities:
BACKGROUND: Among asthmatic subjects, bronchodilator response (BDR) to inhaled beta(2)-adrenergic agonists is variable, and the significance of a consistent response over time is unknown. OBJECTIVE: We assessed baseline clinical variables and determined the clinical outcomes associated with a consistently positive BDR over 4 years in children with mild-to-moderate persistent asthma. METHODS: In the 1041 participants in the Childhood Asthma Management Program, subjects with a change in FEV(1) of 12% or greater (and 200 mL) after inhaled beta(2)-agonist administration at each of their yearly follow-up visits (consistent BDR) were compared with those who did not have a consistent BDR. RESULTS: We identified 52 children with consistent BDRs over the 4-year trial. Multivariable logistic regression modeling demonstrated that lower baseline prebronchodilator FEV(1) values (odds ratio, 0.71; P < .0001), higher log10 IgE levels (odds ratio, 1.97; P = .002), and lack of treatment with inhaled corticosteroids (odds ratio, 0.31; P = .009) were associated with a consistent BDR. Individuals who had a consistent BDR had more hospital visits (P = .007), required more prednisone bursts (P = .0007), had increased nocturnal awakenings caused by asthma (P < .0001), and missed more days of school (P = .03) than nonresponders during the 4-year follow-up. CONCLUSIONS: We have identified predictors of consistent BDR and determined that this phenotype is associated with poor clinical outcomes.
Authors: Aaron Deykin; Michael E Wechsler; Homer A Boushey; Vernon M Chinchilli; Susan J Kunselman; Timothy J Craig; Emily DiMango; John V Fahy; Monica Kraft; Frank Leone; Stephen C Lazarus; Robert F Lemanske; Richard J Martin; Gene R Pesola; Stephen P Peters; Christine A Sorkness; Stanley J Szefler; Elliot Israel Journal: Am J Respir Crit Care Med Date: 2006-09-14 Impact factor: 21.405
Authors: S T Weiss; A A Litonjua; C Lange; R Lazarus; S B Liggett; E R Bleecker; K G Tantisira Journal: Pharmacogenomics J Date: 2006-04-25 Impact factor: 3.550
Authors: Richard J Martin; Stanley J Szefler; Tonya S King; Monica Kraft; Homer A Boushey; Vernon M Chinchilli; Timothy J Craig; Emily A Dimango; Aaron Deykin; John V Fahy; Elliot Israel; Stephen C Lazarus; Robert F Lemanske; Frank T Leone; Gene R Pesola; Stephen P Peters; Christine A Sorkness; Lisa A Szwejbka; Michael E Wechsler Journal: J Allergy Clin Immunol Date: 2007-01 Impact factor: 10.793
Authors: Christine A Sorkness; Robert F Lemanske; David T Mauger; Susan J Boehmer; Vernon M Chinchilli; Fernando D Martinez; Robert C Strunk; Stanley J Szefler; Robert S Zeiger; Leonard B Bacharier; Gordon R Bloomberg; Ronina A Covar; Theresa W Guilbert; Gregory Heldt; Gary Larsen; Michael H Mellon; Wayne J Morgan; Mark H Moss; Joseph D Spahn; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2006-11-30 Impact factor: 10.793
Authors: Robert S Zeiger; Stanley J Szefler; Brenda R Phillips; Michael Schatz; Fernando D Martinez; Vernon M Chinchilli; Robert F Lemanske; Robert C Strunk; Gary Larsen; Joseph D Spahn; Leonard B Bacharier; Gordon R Bloomberg; Theresa W Guilbert; Gregory Heldt; Wayne J Morgan; Mark H Moss; Christine A Sorkness; Lynn M Taussig Journal: J Allergy Clin Immunol Date: 2006-01 Impact factor: 10.793
Authors: Xiaofeng Jiang; Hui Pan; Joseph F Nabhan; Ramaswamy Krishnan; Cynthia Koziol-White; Reynold A Panettieri; Quan Lu Journal: FASEB J Date: 2012-01-25 Impact factor: 5.191
Authors: Andrea M Coverstone; Leonard B Bacharier; Bradley S Wilson; Anne M Fitzpatrick; William Gerald Teague; Wanda Phipatanakul; Sally E Wenzel; Benjamin M Gaston; Eugene R Bleecker; Wendy C Moore; Sima Ramratnam; Nizar N Jarjour; Ngoc P Ly; John V Fahy; David T Mauger; Kenneth B Schechtman; Huiqing Yin-DeClue; Jonathan S Boomer; Mario Castro Journal: Pediatr Pulmonol Date: 2019-08-19
Authors: Jung A Woo; Maria Castaño; Ashley Goss; Donghwa Kim; Eric M Lewandowski; Yu Chen; Stephen B Liggett Journal: FASEB J Date: 2019-08-20 Impact factor: 5.191
Authors: Ronald L Sorkness; Edward M Zoratti; Meyer Kattan; Peter J Gergen; Michael D Evans; Cynthia M Visness; Michelle Gill; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Andrew H Liu; George T O'Connor; Jacqueline A Pongracic; Dinesh Pillai; Christine A Sorkness; Alkis Togias; Robert A Wood; William W Busse Journal: J Allergy Clin Immunol Date: 2017-11-14 Impact factor: 10.793
Authors: John M Brehm; Sima K Ramratnam; Sze Man Tse; Damien C Croteau-Chonka; Maria Pino-Yanes; Christian Rosas-Salazar; Augusto A Litonjua; Benjamin A Raby; Nadia Boutaoui; Yueh-Ying Han; Wei Chen; Erick Forno; Anna L Marsland; Nicole R Nugent; Celeste Eng; Angel Colón-Semidey; María Alvarez; Edna Acosta-Pérez; Melissa L Spear; Fernando D Martinez; Lydiana Avila; Scott T Weiss; Manuel Soto-Quiros; Carole Ober; Dan L Nicolae; Kathleen C Barnes; Robert F Lemanske; Robert C Strunk; Andrew Liu; Stephanie J London; Frank Gilliland; Patrick Sleiman; Michael March; Hakon Hakonarson; Qing Ling Duan; Jay K Kolls; Gregory K Fritz; Donglei Hu; Negar Fani; Jennifer S Stevens; Lynn M Almli; Esteban G Burchard; Jaemin Shin; Elizabeth L McQuaid; Kerry Ressler; Glorisa Canino; Juan C Celedón Journal: Am J Respir Crit Care Med Date: 2015-07-01 Impact factor: 21.405
Authors: Jeffrey D Edelson; Marie Makhlina; Kevin R Silvester; Shailesh S Vengurlekar; Xiaomei Chen; Jie Zhang; Cynthia J Koziol-White; Philip R Cooper; Trevor J Hallam; Douglas W P Hay; Reynold A Panettieri Journal: Pulm Pharmacol Ther Date: 2012-11-12 Impact factor: 3.410
Authors: Devika R Rao; Jonathan M Gaffin; Sachin N Baxi; William J Sheehan; Elaine B Hoffman; Wanda Phipatanakul Journal: J Asthma Date: 2012-06-28 Impact factor: 2.515
Authors: Blanca E Himes; Ann Chen Wu; Qing Ling Duan; Barbara Klanderman; Augusto A Litonjua; Kelan Tantisira; Marco F Ramoni; Scott T Weiss Journal: Pharmacogenomics Date: 2009-09 Impact factor: 2.533